| 3.01 Data as of May 17 | +0.20 / +7.12%Today’s Change | 2.25 Today|||52-Week Range 14.08 | -62.61% Year-to-Date |
The 6 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 2.75, with a high estimate of 6.00 and a low estimate of 1.00. The median estimate represents a -8.64% decrease from the last price of 3.01.

The current consensus among 9 polled investment analysts is to Hold stock in Aveo Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




